ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
暂无分享,去创建一个
David Bonsall | Paolo Piazza | David Buck | M. Azim Ansari | Eleanor Barnes | P. Klenerman | R. Bowden | Camilla L. C. Ip | D. Buck | E. Barnes | A. Trebes | P. Piazza | M. Ansari | D. Bonsall | Camilla Ip | Amy Trebes | Anthony Brown | Paul Klenerman | Rory Bowden | A. Brown | STOP-HCV Consortium | Eleanor Barnes | Paul Klenerman
[1] O. Pybus,et al. Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing , 2015, Journal of Clinical Microbiology.
[2] K. Reddy,et al. Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET. , 2015, Journal of hepatology.
[3] Jolyon Holdstock,et al. Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples , 2015, Journal of Clinical Microbiology.
[4] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[5] John McNally,et al. Sofosbuvir for previously untreated chronic hepatitis C infection. , 2013, The New England journal of medicine.
[6] V. Miller,et al. Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group , 2014, Clinical pharmacology and therapeutics.
[7] C. Rice,et al. Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource , 2013, Hepatology.
[8] Huldrych F. Günthard,et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.
[9] Gabor T. Marth,et al. MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping , 2013, PloS one.
[10] K. Nakayama,et al. Use of Illumina Deep Sequencing Technology To Differentiate Hepatitis C Virus Variants , 2011, Journal of Clinical Microbiology.
[11] A. Flaxman,et al. Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.
[12] F. Baldanti,et al. Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients , 2012, Virology Journal.
[13] O. Pybus,et al. Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection , 2009, Journal of Virology.
[14] S. Brisse,et al. Evaluation of High-Throughput Sequencing for Identifying Known and Unknown Viruses in Biological Samples , 2011, Journal of Clinical Microbiology.
[15] E. Leproust,et al. Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples , 2011, PloS one.
[16] W. Lipkin,et al. Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis , 2015, mBio.
[17] Elizabeth M. Ryan,et al. De novo assembly of highly diverse viral populations , 2012, BMC Genomics.
[18] Juliane C. Dohm,et al. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing , 2008, Nucleic acids research.
[19] F. S. Domingues,et al. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients , 2009, Hepatology.
[20] Florian Hahne,et al. QuasR: quantification and annotation of short reads in R , 2015, Bioinform..
[21] A. Flaxman,et al. Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.
[22] Daniel J. Wilson,et al. A Modified RNA-Seq Approach for Whole Genome Sequencing of RNA Viruses from Faecal and Blood Samples , 2013, PLoS ONE.
[23] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[24] Kevin Galinsky,et al. Hybrid selection for sequencing pathogen genomes from clinical samples , 2011, Genome Biology.
[25] Tarjei S Mikkelsen,et al. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples , 2014, Genome Biology.
[26] Michael D. Miller,et al. Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus , 2015, Journal of Clinical Microbiology.
[27] C. Sabin,et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011 , 2012, HIV medicine.
[28] Xiao Yang,et al. V-Phaser 2: variant inference for viral populations , 2013, BMC Genomics.
[29] A. Hughes,et al. Analysis of Hepatitis C Virus Intrahost Diversity across the Coding Region by Ultradeep Pyrosequencing , 2012, Journal of Virology.
[30] Paolo Piazza,et al. Improved workflows for high throughput library preparation using the transposome-based nextera system , 2013, BMC Biotechnology.
[31] Nihar Shah,et al. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C , 2013, Expert opinion on investigational drugs.
[32] H. Chu,et al. Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease , 2007, Antimicrobial Agents and Chemotherapy.
[33] Sanjeev Arora,et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. , 2014, The New England journal of medicine.
[34] E. Schiff,et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. , 2013, The New England journal of medicine.